May 6, 2026
LTZ Therapeutics
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
- Round
- Venture - Series Unknown
- Amount raised
- $38M
- Lead investor
- Eli Lilly
- Industry
- Biotechnology
- Headquarters
- San Francisco, United States
- Employees
- 11-50
- Website
- www.ltztherapeutics.com
- View profile →
Other investors
- GL Ventures LLC
- K2VC
- Lapam Capital
- Qiming Venture Partners
- Zoo Capital
Source: Crunchbase snapshot 2026-05-15